Clinical Trials Directory

Trials / Sponsors / Neuralstem Inc.

Neuralstem Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
UnknownA Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
Major Depressive Disorder
—2016-08-01
UnknownStudy of NSI-189 for Major Depressive Disorder
Major Depressive Disorder
Phase 22016-03-01
UnknownSafety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
Spinal Cord Injury (SCI)
Phase 12014-08-01
UnknownDose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatme
Amyotrophic Lateral Sclerosis
Phase 22013-05-01
CompletedMultiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patien
Depression
Phase 12012-05-01
CompletedSingle-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189
Depression
Phase 12011-02-01
UnknownHuman Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Phase 12009-01-01